Laboratory Corporation of America Holdings (LH)

Debt-to-assets ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 4,054,700 4,427,600 5,042,400 5,052,300 5,038,800 5,334,300 5,360,300 5,383,300 5,416,500 5,417,200 5,422,600 4,920,900 5,419,000 5,417,300 5,416,600 5,790,200 5,789,800 6,101,300 6,135,000 5,495,600
Total assets US$ in thousands 16,725,100 16,886,000 17,718,700 20,200,000 20,155,100 19,826,000 20,403,100 20,728,400 20,385,400 20,866,500 20,417,100 20,417,100 20,071,700 18,739,600 17,849,100 17,298,400 18,046,400 17,847,800 17,744,400 16,970,800
Debt-to-assets ratio 0.24 0.26 0.28 0.25 0.25 0.27 0.26 0.26 0.27 0.26 0.27 0.24 0.27 0.29 0.30 0.33 0.32 0.34 0.35 0.32

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $4,054,700K ÷ $16,725,100K
= 0.24

The debt-to-assets ratio for Laboratory Corp. Of America Holdings has been relatively stable over the past eight quarters, ranging from 0.26 to 0.33. This ratio indicates the proportion of the company's assets financed by debt, with lower values suggesting lower financial risk. The ratio peaked at 0.33 in Q3 2023 and Q2 2023, reflecting a higher level of debt compared to assets during those periods. Conversely, in Q1 2022 and Q4 2022, the ratio was at its lowest at 0.26, indicating a higher proportion of assets financed by equity. Overall, the company appears to maintain a conservative debt-to-assets structure, which is generally viewed positively by investors and creditors.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-assets ratio
Laboratory Corporation of America Holdings
LH
0.24
Fortrea Holdings Inc.
FTRE
0.36
Fulgent Genetics Inc
FLGT
0.00
Quest Diagnostics Incorporated
DGX
0.31
RadNet Inc
RDNT
0.30